Premium
Aggressive invasive micropapillary salivary duct carcinoma of the parotid gland
Author(s) -
Yamamoto Hidetaka,
Uryu Hideoki,
Segawa Yuichi,
Tsuneyoshi Masazumi
Publication year - 2008
Publication title -
pathology international
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.73
H-Index - 74
eISSN - 1440-1827
pISSN - 1320-5463
DOI - 10.1111/j.1440-1827.2008.02231.x
Subject(s) - salivary duct carcinoma , pathology , lymph , medicine , immunohistochemistry , salivary gland , parotid gland , carcinoma
The presence of invasive micropapillary component has been reported to be associated with salivary duct carcinoma and poor outcomes. Herein is described a rare case of invasive micropapillary salivary duct carcinoma of the parotid gland in a 60‐year‐old man. The micropapillary component was approximately 70% of the area of the tumor. Squamous differentiation was focally seen adjacent to the micropapillary component. On immunohistochemistry the ordinary salivary duct carcinoma component was positive for gross cystic disease fluid protein‐15 (GCDFP‐15), androgen receptor (AR), and HER2/neu, whereas both micropapillary and squamous components were negative for GCDFP‐15 and AR. Immunohistochemical staining for D2‐40 highlighted the lymph vessel invasion of tumor cells. This patient developed metastases in the lymph nodes of the neck, and also in the liver, lung, and brain. The lymph nodes and liver metastases had both ordinary salivary duct carcinoma and micropapillary components. The patient died of tumor 11 months after the initial surgical operation. The results support that the presence of micropapillary component is associated with more aggressive behavior of salivary duct carcinoma. It is also important for pathologists to recognize that GCDFP‐15 and AR expression can be reduced in micropapillary carcinoma in the differential diagnosis of metastatic tumor.